ID

31787

Descrizione

Study ID: 105-040 Clinical Study ID: 105-040 Study Title: A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Design Evaluation of LAMICTAL for Add-on Treatment of Partial Seizures in Pediatric Patients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: lamotrigine Trade Name: lamictal Study Indication: Epilepsy, Partial

Keywords

  1. 18/09/18 18/09/18 -
  2. 27/09/18 27/09/18 -
  3. 08/10/18 08/10/18 -
Titolare del copyright

GlaxoSmithKline

Caricato su

27 settembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Evaluation of LAMICTAL for Add-on Treatment of Partial Seizures in Pediatric Patients (Clinical Study ID: 105-040)

Adverse Experiences

  1. StudyEvent: ODM
    1. Adverse Experiences
Administrative
Descrizione

Administrative

Alias
UMLS CUI-1
C1320722
Site number
Descrizione

Study Site; Numbers

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2825164
UMLS CUI [1,2]
C0237753
Patient's initials
Descrizione

Person Initials

Tipo di dati

text

Alias
UMLS CUI [1]
C2986440
Paritient's trial number
Descrizione

Clinical Trial Subject Unique Identifier

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
Occurence of Adverse Experiences
Descrizione

Occurence of Adverse Experiences

Alias
UMLS CUI-1
C0877248
UMLS CUI-2
C2745955
Did any adverse experiences occur during Baseline through Taper and Follow- up?
Descrizione

If yes, record below- one adverse experience per section

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C1442488
UMLS CUI [2,1]
C0877248
UMLS CUI [2,2]
C1522577
Adverse Experiences
Descrizione

Adverse Experiences

Alias
UMLS CUI-1
C0877248
Specification of Adverse Experience
Descrizione

Adverse event; Specification

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C2348235
Adverse Experience start date
Descrizione

Adverse Event Start Date

Tipo di dati

date

Alias
UMLS CUI [1]
C2697888
Adverse Experience stop date
Descrizione

Adverse event; End date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0806020
If Adverse Experience is ongoing at end of study, check.
Descrizione

Adverse Event Ongoing

Tipo di dati

integer

Alias
UMLS CUI [1]
C2826663
Maximum intensity of Adverse Experience, check one.
Descrizione

Severity of Adverse Event

Tipo di dati

integer

Alias
UMLS CUI [1]
C1710066
Maximum seriousness of Adverse Experience
Descrizione

Seriousness of Adverse Event

Tipo di dati

integer

Alias
UMLS CUI [1]
C1710056
Is the Adverse Experience caused by study drug? Check one.
Descrizione

Adverse event; Experimental drug

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0304229
Action taken due to adverse experience - Study drug dose; check one.
Descrizione

Adverse Event Action Taken with Study Treatment; Drug dose

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C2826626
UMLS CUI [1,2]
C0678766
Action taken due to Adverse Experience - Other action taken
Descrizione

Adverse Event Action Taken with Study Treatment; Other

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C2826626
UMLS CUI [1,2]
C0205394
If other action taken due to Adverse Experience, specify
Descrizione

Adverse Event Action Taken with Study Treatment; Other; Specification

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2826626
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C2348235
Comments
Descrizione

Comment

Tipo di dati

text

Alias
UMLS CUI [1]
C0947611

Similar models

Adverse Experiences

  1. StudyEvent: ODM
    1. Adverse Experiences
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Study Site; Numbers
Item
Site number
text
C2825164 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Person Initials
Item
Patient's initials
text
C2986440 (UMLS CUI [1])
Clinical Trial Subject Unique Identifier
Item
Paritient's trial number
text
C2348585 (UMLS CUI [1])
Item Group
Occurence of Adverse Experiences
C0877248 (UMLS CUI-1)
C2745955 (UMLS CUI-2)
Adverse event; Baseline | Adverse event; follow-up
Item
Did any adverse experiences occur during Baseline through Taper and Follow- up?
boolean
C0877248 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C0877248 (UMLS CUI [2,1])
C1522577 (UMLS CUI [2,2])
Item Group
Adverse Experiences
C0877248 (UMLS CUI-1)
Adverse event; Specification
Item
Specification of Adverse Experience
text
C0877248 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Adverse Event Start Date
Item
Adverse Experience start date
date
C2697888 (UMLS CUI [1])
Adverse event; End date
Item
Adverse Experience stop date
date
C0877248 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
If Adverse Experience is ongoing at end of study, check.
integer
C2826663 (UMLS CUI [1])
Code List
If Adverse Experience is ongoing at end of study, check.
CL Item
Ongoing Adverse Experience at end of study (1)
Item
Maximum intensity of Adverse Experience, check one.
integer
C1710066 (UMLS CUI [1])
Code List
Maximum intensity of Adverse Experience, check one.
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Item
Maximum seriousness of Adverse Experience
integer
C1710056 (UMLS CUI [1])
Code List
Maximum seriousness of Adverse Experience
CL Item
Not serious (1)
CL Item
Serious (2)
Item
Is the Adverse Experience caused by study drug? Check one.
integer
C0877248 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Code List
Is the Adverse Experience caused by study drug? Check one.
CL Item
Not a reasonable possibility (1)
CL Item
A reasonable possibility (2)
Item
Action taken due to adverse experience - Study drug dose; check one.
integer
C2826626 (UMLS CUI [1,1])
C0678766 (UMLS CUI [1,2])
Code List
Action taken due to adverse experience - Study drug dose; check one.
CL Item
Unchanged (1)
CL Item
Increased (2)
CL Item
Decreased and/ or stopped temporarily (3)
CL Item
Stopped permanently (4)
Item
Action taken due to Adverse Experience - Other action taken
integer
C2826626 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Code List
Action taken due to Adverse Experience - Other action taken
CL Item
No (1)
CL Item
Hosp. (2)
CL Item
Other, specify (3)
Adverse Event Action Taken with Study Treatment; Other; Specification
Item
If other action taken due to Adverse Experience, specify
text
C2826626 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Comment
Item
Comments
text
C0947611 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial